TY - JOUR
T1 - Efficacy of coronary heart disease stenting in small vessels versus balloon angioplasty study - CHIVAS Study Trial
AU - Muramatsu, Toshiya
AU - Inoue, Naoto
AU - Iwasaki, Koichiro
AU - Horita, Yuhki
AU - Tanaka, Shigehiro
AU - Fujita, Naoya
AU - Namura, Masanobu
AU - Awano, Kojiro
AU - Shirasaka, Akihiro
AU - Ueda, Kinzo
AU - Kamiya, Haruo
AU - Murakami, Mikitaka
AU - Ozaki, Yukio
AU - Namiki, Aturo
AU - Takada, Hiroyuki
AU - Sakakibara, Masayoshi
AU - Takatsu, Yoshiki
AU - Suesada, Hiroyuki
AU - Mori, Masunori
AU - Yasaka, Yoshinori
AU - Wagatsuma, Kenji
AU - Hikichi, Yutaka
AU - Sakurada, Masami
PY - 2005/12/1
Y1 - 2005/12/1
N2 - This study enrolled 302 patients with angina or ischemic heart disease, in which elective stent placement could be performed, at 25 medical centers in Japan between April 1998 and July 2000. Patients were divided into diabetic and non-diabetic groups, and subsequently assigned to either a plain old balloon angioplasty (POBA) or a stent group by an envelope method. The subjects were assigned to stent (148 subjects) and POBA (154) groups. Acute gain in the stent group was better than that in the POBA group (1.08 mm vs. 0.84 mm). In contrast, there were no differences in late loss between the two groups. Binary restenosis in coronary angioplasty after 6 months in the stent group was 30.8%, significantly lower than that in the POBA group (43.5%). Major adverse cardiac events and TLR were not significantly different between the two groups. Restenosis in diabetes mellitus: In patients with diabetes mellitus, the rate of restenosis was significantly lower in the stent group compared to the POBA group (23.7% vs. 55.3%). We concluded that MULTI-LINK stents for small vessels (>3.0 mm) have better outcomes of 6 month restenosis rate rather than that of POBA, and especially in patients with diabetes mellitus.
AB - This study enrolled 302 patients with angina or ischemic heart disease, in which elective stent placement could be performed, at 25 medical centers in Japan between April 1998 and July 2000. Patients were divided into diabetic and non-diabetic groups, and subsequently assigned to either a plain old balloon angioplasty (POBA) or a stent group by an envelope method. The subjects were assigned to stent (148 subjects) and POBA (154) groups. Acute gain in the stent group was better than that in the POBA group (1.08 mm vs. 0.84 mm). In contrast, there were no differences in late loss between the two groups. Binary restenosis in coronary angioplasty after 6 months in the stent group was 30.8%, significantly lower than that in the POBA group (43.5%). Major adverse cardiac events and TLR were not significantly different between the two groups. Restenosis in diabetes mellitus: In patients with diabetes mellitus, the rate of restenosis was significantly lower in the stent group compared to the POBA group (23.7% vs. 55.3%). We concluded that MULTI-LINK stents for small vessels (>3.0 mm) have better outcomes of 6 month restenosis rate rather than that of POBA, and especially in patients with diabetes mellitus.
UR - http://www.scopus.com/inward/record.url?scp=31444457186&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=31444457186&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:31444457186
VL - 20
SP - 491
EP - 497
JO - Japanese Journal of Interventional Cardiology
JF - Japanese Journal of Interventional Cardiology
SN - 0914-8922
IS - 6
ER -